Atlas Trials

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Clinical trial NCT07336940 · COMPLETED

Trial details

NCT number
NCT07336940
Sponsor
Enveda Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Atopic Dermatitis (AD)
Start date
2025-09-10
Primary completion
2026-01-13
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.